ReproCell Akcija

ReproCell CROIC

Vrijednost Gotovinski povrat na uloženi kapital (CROIC) od ReproCell (4978.T) na dan 14. авг 2026. je -0,89 %. Prethodne godine, Gotovinski povrat na uloženi kapital (CROIC) je bio -2,20 % — promjena od -59,33% (viši).

CROIC

-0,89 %

YoY

-59,33%

Zadnja ažuriranja:

Gotovinski povrat na uloženi kapital (CROIC) od ReproCell je 2026 -0,89 % . Gotovinski povrat na uloženi kapital (CROIC) od ReproCell je bio 2025 -2,20 % . Pad je time -59,33% viši u odnosu na prethodnu godinu.
Access this data via the Eulerpool API

ReproCell Анализа акција

Šta radi ReproCell? ReproCell, Inc. is a company that was founded in 2003 and specializes in the research and manufacture of cell cultures. The company is based in Yokohama, Japan and operates worldwide. Its business model includes providing services and products to support research and development activities in the field of regenerative medicine and cell therapy. The company is divided into three main divisions: the Biorepository Division, which provides human cells and tissues for research purposes; the Cell Manufacturing Division, which develops production processes for cell therapy products; and the Drug Discovery Division, which supports drug development through screening and in vitro testing. ReproCell offers a variety of cell cultures, including stem cells from various sources, as well as related media, reagents, and tools for cultivation and application. In addition, the company offers services in cell therapy production, working closely with customers to provide customized and high-quality therapies. ReproCell also supports drug and compound research through screening and in vitro testing, with various platforms available for the identification and evaluation of new compounds. The company has a history of growth and has become a leading player in the field of cell culture and cell therapy production. In conclusion, ReproCell plays a significant role in regenerative medicine and cell therapy production, offering a wide range of products and services to support research and development in these areas. It is poised to continue its growth and contribute to the development of new therapies in the future. ReproCell je jedna od najpopularnijih kompanija na Eulerpool.

Često postavljena pitanja o akciji ReproCell

Gotovinski povrat na uloženi kapital (CROIC) kompanije ReproCell iznosi -0,89 % u 2026. godini.

Gotovinski povrat na uloženi kapital (CROIC) od ReproCell se promijenio sa -2,20 % na -0,89 %, što predstavlja promjenu od -59,33%. Vrijednost je viši nego prethodne godine.

Na Eulerpool-u možete pronaći potpuni historijski razvoj Gotovinski povrat na uloženi kapital (CROIC) ReproCell od 2006. — sa godišnjim vrijednostima, grafikonima i detaljnom analizom.

CROIC мери готинску исплату генерисану на уложеном капиталу. За разлику од ROIC, користи слободан готински ток уместо рачуноводствене добити, пружајући чишћу меру профитабилности.

Dobar varira u zavisnosti od industrije i faze razvoja preduzeća. Na Eulopoolu, možete porediti Gotovinski povrat na uloženi kapital (CROIC)'s ReproCell sa sličnim preduzećima u sektoru i prosekom industrije da biste proverili da li je atraktivan.

Da biste proverili Gotovinski povrat na uloženi kapital (CROIC)'s, bitno je da ga uporedite sa konkurentima u istoj industriji i sektoru. Na Eulopoolu, možete pronaći direktna upoređivanja industrije za Gotovinski povrat na uloženi kapital (CROIC).

Access this data via the Eulerpool API

Профитабилност — ReproCell

Sve ključne metrike — ReproCell

Раст